Zobrazeno 1 - 10
of 235
pro vyhledávání: '"ER, Estrogen Receptor"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hiral Samir Shah, Neema Ankur Rana, Meena Rajiv Daveshwar, Amrish N Shah, Pankti I Macwan, Hena D Sodha, Kinjal D Patel
Publikováno v:
National Journal of Medical Research, Vol 10, Iss 02 (2020)
Introduction: Breast carcinoma is the most common malignant tumor worldwide and leading cause ofdeath in women .Present study was aimed to study patterns of expression of Hormone receptor (ER PR) andHer-2/neu in invasive breast carcinoma and to corre
Externí odkaz:
https://doaj.org/article/c45b9bf089c34bb2824c0a74bb516994
Bilateral breast metastases from small cell lung carcinoma: Case report and review of the literature
Autor:
Emad Allam, Luke Freiburg, John Olivieri, Vijayalakshmi Ananthanarayanan, Shuchi Zinzuwadia, Cheryl Zhang
Publikováno v:
Radiology Case Reports, Vol 16, Iss 7, Pp 1718-1726 (2021)
Radiology Case Reports
Radiology Case Reports
Differentiation of primary versus secondary breast cancer can be difficult, with the relative rarity of the latter representing a diagnostic challenge. Here, we present a case of small cell lung cancer with synchronous bilateral breast metastases in
Autor:
Hanan E. Al-Rashidi, Dalia T Hussein, Sherif Refaat, Enas Ahmed, Fatma M. El-Tantawy, Sahar Hamed
Publikováno v:
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)
According Global Cancer Statistics 2020 GLOBOCAN estimates female breast cancer was found as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), and the fourth leading cause (6.9%) of cancer death among women worldwid
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Breast cancer arises as a result of multiple interactions between environmental and genetic factors. Conventionally, breast cancer is treated based on histopathological and clinical features. DNA technologies like the human genome microarray are now
Publikováno v:
Advanced Drug Delivery Reviews
Graphical abstract
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Publikováno v:
Genes and Diseases, Vol 8, Iss 2, Pp 117-123 (2021)
Genes & Diseases
Genes & Diseases
Breast cancer is the second highest prevalent cancer globally after lung cancer with 2.09 million cases during 2018. Adults about 1.9 billion were overweight and over 650 million out of these were obese during 2016. There is a significant relationshi
Autor:
Deidre M. Mattiske, Andrew J Pask
Publikováno v:
Current Research in Toxicology, Vol 2, Iss, Pp 179-191 (2021)
Current Research in Toxicology
Current Research in Toxicology
Graphical abstract
Highlights • Penis development is regulated by a tight balance of androgens and estrogens. • EDCs that impact androgen/estrogen balance during development cause hypospadias. • Cross-disciplinary collaborations are needed
Highlights • Penis development is regulated by a tight balance of androgens and estrogens. • EDCs that impact androgen/estrogen balance during development cause hypospadias. • Cross-disciplinary collaborations are needed
Publikováno v:
Toxicology Reports, Vol 8, Iss, Pp 1002-1007 (2021)
Toxicology Reports
Toxicology Reports
Highlights • Benzyl salicylate (BS) is on priority lists for evaluation of estrogenic effects. • New data in both MCF7 (E-screen) and luciferase transactivation assays. • Potency of BS is 21′000′000-fold lower than estradiol in transactivat
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 1, Pp 30-54 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
The sustained cell proliferation resulting from dysregulation of the cell cycle and activation of cyclin-dependent kinases (CDKs) is a hallmark of cancer. The inhibition of CDKs is a highly promising and attractive strategy for the development of ant